IESHSA ENGLE: Open Payments
NPI 1740753946 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 70 payments from 25 companies in 2025. Trend: 2023 $964 · 2024 $1,656 · 2025 $1,177
Food & beverage: $1,000Education: $177
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $202 |
| Astellas Pharma US Inc | 4 | $200 |
| PFIZER INC. | 12 | $165 |
| Eisai Inc. | 5 | $124 |
| Adaptive Biotechnologies Corporation | 2 | $49 |
| Genentech USA, Inc. | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| GENZYME CORPORATION | 1 | $28 |
Products named: Lenvima, LUTATHERA, PADCEV, KISQALI, clonoSEQ, XTANDI, LIBTAYO, SARCLISA.
Industry payments across IN — which companies pay providers there.
